Biodesix's market cap is currently ―. The company's EPS TTM is $-0.647; its P/E ratio is -1.98; Biodesix is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 14.67M	$ 13.49M	$ 11.87M	$ 9.06M	$ 9.61M
Gross Profit	$ 14.67M	$ 13.49M	$ 11.87M	$ 9.06M	$ 9.61M
EBIT	$ -62.00K	$ -2.10M	$ -4.45M	$ -16.31M	$ -17.79M
EBITDA	$ 2.40M	-	$ -1.69M	$ -13.41M	$ -16.12M
Net Income Common Stockholders	$ -9.14M	$ -4.49M	$ -13.36M	$ -18.70M	$ -20.34M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 26.28M	$ 19.80M	$ 17.41M	$ 25.27M	$ 43.09M
Total Assets	$ 99.10M	$ 86.79M	$ 77.62M	$ 80.79M	$ 92.91M
Total Debt	$ 60.69M	$ 50.75M	$ 45.02M	$ 38.94M	$ 31.85M
Net Debt	$ 34.41M	$ 30.95M	$ 27.61M	$ 13.66M	$ -11.24M
Total Liabilities	$ 94.52M	$ 88.23M	$ 84.65M	$ 76.24M	$ 72.30M
Stockholders Equity	$ 4.58M	$ -1.45M	$ -6.99M	$ 4.55M	$ 20.61M
Cash Flow	-
Free Cash Flow	$ -15.27M	-	$ -5.50M	$ -15.36M	$ -13.88M
Operating Cash Flow	$ -12.28M	$ -3.84M	$ 922.00K	$ -7.69M	$ -11.95M
Investing Cash Flow	$ -3.00M	$ -5.88M	$ -6.47M	$ -7.71M	$ -1.99M
Financing Cash Flow	$ 21.73M	$ 12.15M	$ -2.33M	$ -2.42M	$ 41.85M

Currency in USD

Biodesix Earnings and Revenue History

Income Statement >

Biodesix Debt to Assets

Balance Sheet >

Biodesix Cash Flow

Cash Flow >

Biodesix Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing